WallStreetZenWallStreetZen

NASDAQ: AKYA
Akoya Biosciences Inc Stock Ownership - Who owns Akoya Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Akoya Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Pascal BamfordChief Clinical Officer2025-06-01670$1.25
$837.50Sell
John Frederick EkCFO2025-04-0116,432$1.35
$22.18kSell
Brian McKelligonPresident and CEO2025-03-237,550$1.70
$12.84kSell
Niro Phd RamachandranChief Business Officer2025-03-232,310$1.70
$3.93kSell
Pascal BamfordChief Clinical Officer2025-03-011,283$1.63
$2.09kSell
Brian McKelligonPresident and CEO2025-03-017,550$1.63
$12.31kSell
Brian McKelligonPresident and CEO2025-03-018,257$1.63
$13.46kSell
Niro Phd RamachandranChief Business Officer2025-03-012,310$1.63
$3.77kSell
Niro Phd RamachandranChief Business Officer2025-03-013,594$1.63
$5.86kSell
Jennifer KamocsayChief Legal Officer2025-03-013,594$1.63
$5.86kSell

1 of 2

AKYA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AKYA insiders and whales buy or sell their stock.

AKYA Shareholders

What type of owners hold Akoya Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Thomas A. Raffin33.29%16,601,311$20.59MInsider
Thomas P. Schnettler11.14%5,556,492$6.89MInsider
Blue Water Life Science Advisors LP9.42%4,697,785$5.83MInstitution
Blackrock Inc3.23%1,612,002$2.00MInstitution
Vanguard Group Inc2.78%1,388,200$1.72MInstitution
Matthew Winkler1.97%984,513$1.22MInsider
Robert G. Shepler1.55%774,184$959.99kInsider
Paragon Associates Paragon Associates II Joint Venture1.35%671,000$832.04kInstitution
Geode Capital Management LLC1.14%566,982$703.06kInstitution
Garry Phd Nolan1.11%555,084$688.30kInsider

1 of 3

AKYA vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AKYA25.21%52.73%Net SellingNet Selling
MLSS5.33%65.19%Net BuyingNet Selling
NEPH6.01%93.99%
POCI14.91%85.09%Net BuyingNet Buying
MBOT5.93%87.50%
View Top Medical Stocks

Akoya Biosciences Stock Ownership FAQ

Who owns Akoya Biosciences?

Akoya Biosciences (NASDAQ: AKYA) is owned by 25.21% institutional shareholders, 52.73% Akoya Biosciences insiders, and 22.06% retail investors. Thomas A. Raffin is the largest individual Akoya Biosciences shareholder, owning 16.60M shares representing 33.29% of the company. Thomas A. Raffin's Akoya Biosciences shares are currently valued at $20.59M.

If you're new to stock investing, here's how to buy Akoya Biosciences stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.